Efficacy of Short-Term Androgen Deprivation With High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer in Japan

Urology

Volumn 72, Issue 6, 2008, Pages 1335-1340

  Sumitomo, Makoto ^a   Hayashi, Mutsuo ^b   Watanabe, Tetsuya ^c   Tsugawa, Masaya ^d   Noma, Hideya ^e   Yamaguchi, Akito ^e   Nagakura, Kazuhiko ^f   Hayakawa, Masamichi ^a   Uchida, Toyoaki ^g  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Takanobashi Chuo Hospital   (Japan)

^c Maruyama Hospital   (Japan)

^d Okayama Citizens Hospital   (Japan)

^e HARASANSHIN HOSPITAL   (Japan)

^f Department of Urology   (Japan)

^g TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOADJUVANT ANDROGEN DEPRIVATION THERAPY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANDROGENS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 56449101814     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.12.041     Document Type: Article

References (19)

1. Madersbacher S., Pedevilla M., Vingers L., et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55 (1995) 3346-3351
2. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 5 (2005) 321-327
3. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 14 (2000) 519-528
4. Cooperberg M.R., Grossfeld G.D., Lubeck D.P., et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst 95 (2003) 981-989
5. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
6. D'Amico A.V., Manola J., Loffredo M., et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292 (2004) 821-827
7. Uchida T., Illing R.O., Cathcart P.J., et al. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy. BJU Int 98 (2006) 770-772
8. Poissonnier L., Chapelon J.Y., Rouviere O., et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51 (2007) 381-387
9. Uchida T., Ohkusa H., Yamashita H., et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 13 (2006) 228-233
10. American Joint Committee on Cancer. Prostate. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual (2002), Springer, New York 337-345
11. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
12. National Cancer Institute-Cancer Therapy Evaluation Program: Common toxicity criteria, version 2.0. April 30, 1999. Available at: http://ctep.info.nih.gov.
13. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
14. Ash D., Al-Qaisieh B., Bottomley D., et al. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer. Radiother Oncol 75 (2005) 303-306
15. Potters L., Torre T., Ashley R., et al. Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. J Clin Oncol 18 (2000) 1187-1192
16. Zietman A.L., Prince E.A., Nakfoor B.M., et al. Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results. Urology 49 (1997) 74-83
17. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
18. Stock R.G., Stone N.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41 (1998) 101-108
19. Ficarra V., Antoniolli S.Z., Novara G., et al. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int 98 (2006) 1193-1198